What is the significance of finding acanthocytes in the blood of a patient with anemia and how should it be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acanthocytes in Anemia: Significance and Management

Acanthocytes (spur cells) in the setting of anemia most commonly indicate severe end-stage liver disease with hemolytic anemia, or rarely, abetalipoproteinemia/hypobetalipoproteinemia causing fat-soluble vitamin malabsorption.

Pathophysiology and Clinical Significance

Acanthocytes are spiculated red blood cells with irregular membrane projections caused by abnormal lipid composition of the erythrocyte membrane. 1, 2

In adults with anemia, acanthocytosis signals:

  • Spur cell anemia from alcoholic cirrhosis - the most common cause, indicating end-stage liver disease with poor prognosis 1
  • Altered cholesterol-to-phospholipid ratio in RBC membranes leads to abnormal membrane fluidity 2
  • These abnormal cells have shortened survival and undergo splenic sequestration and destruction, causing hemolytic anemia 1
  • The presence of spur cell anemia in cirrhosis typically indicates terminal liver disease 1

Less common causes include:

  • Abetalipoproteinemia or familial hypobetalipoproteinemia due to APOB gene mutations 3
  • Hemochromatosis complicated by liver disease 4

Diagnostic Workup

Immediate laboratory assessment should include:

  • Reticulocyte count to confirm hemolysis (will be elevated) 5
  • Liver function tests (AST, ALT, bilirubin, albumin, PT/INR) to assess severity of hepatic dysfunction 1, 4
  • Lipid profile and lipoprotein analysis if liver disease is not evident 3, 2
  • Peripheral blood smear examination under light microscopy and in counting chamber (EDTA blood may show higher percentage of acanthocytes than standard smear) 2

If liver disease is confirmed:

  • Determine etiology: alcohol history, viral hepatitis serologies, iron studies for hemochromatosis, autoimmune markers 4
  • Assess for complications of cirrhosis (ascites, encephalopathy, varices) 1

If liver disease is absent or minimal:

  • Fasting lipid panel and apolipoprotein B levels 3
  • Fat-soluble vitamin levels (A, D, E, K) 3
  • Consider genetic testing for APOB mutations if hypobetalipoproteinemia suspected 3

Management Approach

For spur cell anemia with alcoholic cirrhosis:

  • Liver transplantation is the only definitive treatment and can completely reverse the hemolytic anemia 1
  • Supportive care with transfusions as needed for symptomatic anemia 1
  • Absolute alcohol cessation is mandatory (recurrence occurs with resumed alcohol intake even post-transplant) 1
  • Splenectomy and corticosteroids are ineffective 1
  • Evaluate for transplant candidacy urgently, as this finding indicates end-stage disease 1

For abetalipoproteinemia/hypobetalipoproteinemia:

  • High-dose fat-soluble vitamin supplementation (vitamins A, D, E, K) can arrest progressive neurological complications 3
  • Low-fat diet to minimize steatorrhea 3
  • Important caveat: acanthocytosis persists despite treatment, but neurological progression can be prevented 3

Critical Pitfalls to Avoid

  • Do not assume acanthocytosis is benign - in the context of anemia, it signals serious underlying disease requiring urgent evaluation 1
  • Standard blood smears may underestimate the degree of acanthocytosis; examination of EDTA blood in a counting chamber reveals higher percentages 2
  • In cirrhotic patients with spur cell anemia, this is not simply a marker of disease but indicates terminal liver failure requiring transplant evaluation 1
  • Screen first-degree relatives when hemochromatosis is identified, as this has important genetic implications 4
  • Continued alcohol use will cause recurrence of spur cell anemia even after successful liver transplantation 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.